Mirum Pharmaceuticals Inc (MIRM)
25.72
+0.61
(+2.43%)
USD |
NASDAQ |
May 01, 16:00
25.72
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Debt to Equity Ratio: 1.232 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.232 |
| September 30, 2023 | 1.137 |
| June 30, 2023 | 3.888 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
3.888
Maximum
Jun 2023
0.5688
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Gilead Sciences Inc | 0.00 |
| Vanda Pharmaceuticals Inc | 0.00 |
| Sarepta Therapeutics Inc | 1.441 |
| Puma Biotechnology Inc | 1.865 |
| Reneo Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 646.62M |
| Total Liabilities (Quarterly) | 397.95M |
| Shareholders Equity (Quarterly) | 248.67M |
| Current Ratio | 4.451 |
| Net Debt Paydown Yield | -4.44% |